Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin in Oligoasthenoteratozoospermia
IRCT20230621058550N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of quercetin in oligoasthenoteratospermia (OAT), sponsored by Tehran University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
quercetin
03
Conditions
oligoasthenoteratospermia (OAT)
Beyond the preview
Go deeper on IRCT20230621058550N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230621058550N1.